Key result
LVEF improvement >10% after CABG in ischemic cardiomyopathy is linked to ~57% lower all-cause mortality.
Why the study?
The extent, direction, and implications of perioperative changes in LVEF in patients with left ventricular systolic dysfunction undergoing CABG have not been well characterized.
Does CABG improve LVEF in patients with ischemic cardiomyopathy and LVEF <50%, and is this improvement associated with survival?
Observational (n=549)
Yes
Does CABG improve LVEF in patients with ischemic cardiomyopathy and LVEF <50%, and is this improvement associated with survival?
Effect estimate: HR 0.43 (95% CI 0.26-0.71)
In patients with ischemic cardiomyopathy undergoing CABG, a >10% improvement in LVEF occurs in about a quarter of patients and is associated with significantly improved long-term survival.
LVEF improvement after CABG identifies lower mortality risk in ischemic cardiomyopathy; leaves open predictors of response and need for prospective trials.
BACKGROUND: Nearly 1/3rd of patients undergoing coronary artery bypass graft surgery (CABG) have left ventricular systolic dysfunction. However, the extent, direction and implications of perioperative changes in left ventricular ejection fraction (LVEF) have not been well characterized in these patients. METHODS: We studied the changes in LVEF among 549 patients with left ventricular systolic dysfunction (LVEF <50%) who underwent CABG as part of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. Patients had pre- and post-CABG (4 month) LVEF assessments using identical cardiac imaging modality, interpreted at a core laboratory. An absolute change of >10% in LVEF was considered clinically significant. RESULTS: Of the 549 patients (mean age 61.4±9.55 years, and 72 [13.1%] women), 145 (26.4%) had a >10% improvement in LVEF, 369 (67.2%) had no change and 35 (6.4%) had >10% worsening of LVEF following CABG. Patients with lower preoperative LVEF were more likely to experience an improvement after CABG (odds ratio 1.36; 95% CI 1.21-1.53; per 5% lower preoperative LVEF; p <0.001). Notably, incidence of postoperative improvement in LVEF was not influenced by presence, nor absence, of myocardial viability (25.5% vs. 28.3% respectively, p = 0.67). After adjusting for age, sex, baseline LVEF, and NYHA Class, a >10% improvement in LVEF after CABG was associated with a 57% lower risk of all-cause mortality (HR: 0.43, 95% CI: 0.26-0.71). CONCLUSIONS: Among patients with ischemic cardiomyopathy undergoing CABG, 26.4% had >10% improvement in LVEF. An improvement in LVEF was more likely in patients with lower preoperative LVEF and was associated with improved long-term survival.
No takes yet. Share an insight, caveat, or question.
Downey et al. (2022) conducted an observational in Ischemic cardiomyopathy with left ventricular systolic dysfunction (n=549). Coronary artery bypass graft surgery (CABG) was evaluated on All-cause mortality associated with >10% improvement in LVEF (HR 0.43, 95% CI 0.26-0.71). A >10% improvement in LVEF after CABG occurred in 26.4% of patients with ischemic cardiomyopathy and was associated with a 57% lower risk of all-cause mortality (HR 0.43; 95% CI 0.26-0.71).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: